Clinical trial

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

NCT07207564

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Non-Interventional Study Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-08-28

PhaseN/A

Conditions

Breast Carcinomaverified · MONDO: breast carcinoma

Interventions

Non-Interventional StudyOTHER

Sponsors & collaborators

Mayo Cliniclead sponsor

Mapped research locations

JacksonvilleFlorida, United States1 RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07207564 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.